Headline News about Replimune Group Inc
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/06/07/Image22.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/06/06/Image48.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/06/Saudi-Arabia--Russia--Usa-Oil-Price-War-.jpeg?width=1200&height=800&fit=crop)
Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings
June 06, 2024
Via Benzinga
Exposures
Fossil Fuels
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Replimune Group: Q3 Earnings Insights
February 08, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Replimune Group
August 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/06/xrdDAFlJKNXbrw2-j4527636209394207909-t23_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/06/06/REPL.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/06/06/xrdDAFlBgQqXKI2-j3472667867116897537-t23.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Replimune Group
June 07, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: Replimune Group Q4 Earnings
May 18, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/05/image44.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/05/daktronics_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/05/image47.jpg?width=1200&height=800&fit=crop)
Dow Falls 100 Points; ISM Services PMI Increases In November
December 05, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/05/image33.jpeg?width=1200&height=800&fit=crop)
US Stocks Down; JM Smucker Posts Upbeat Earnings
December 05, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/12/05/repl.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/options_image_2.jpeg?width=1200&height=800&fit=crop)
8 Health Care Stocks Whale Activity In Today's Session
November 07, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2023/06/Stock-Apple-VisionProGoggles-01-company.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/05/amedisys_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2023/06/IT03_ImmunoGen_060523news.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/13/image27.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/12/logo_light__3959434ad89734e0e649ecfca0aee813.png?width=1200&height=800&fit=crop)
Analyst Beefs Up Replimune Price Target As Recent Data Validates Treatment Platform
December 12, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.